UNIGE document Scientific Article
previous document  unige:120077  next document
add to browser collection
Title

Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients

Authors
Grandjean Hallez, Nicole
show hidden authors show all authors [1 - 21]
Published in Neuro-Oncology. 2019
Abstract Peptide vaccines offer the opportunity to elicit glioma-specific T cells with tumor killing ability. Using antigens eluted from the surface of glioblastoma samples, we designed a phase I/II study to test safety and immunogenicity of the IMA950 multipeptide vaccine adjuvanted with poly-ICLC in HLA-A2 + glioma patients.
Identifiers
PMID: 30753611
Full text
Article (Author postprint) (1 MB) - public document Free access
Structures
Research groups La Sclérose en plaques (908)
Immunobiologie des tumeurs du cerveau (669)
Immunothérapie des cancers (42)
Citation
(ISO format)
MIGLIORINI, Denis et al. Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients. In: Neuro-Oncology, 2019. https://archive-ouverte.unige.ch/unige:120077

37 hits

13 downloads

Update

Deposited on : 2019-06-26

Export document
Format :
Citation style :